reported Revenues from hospital operations of Thai Baht 886.04 million, a 38.85% improvement year-over-year from Baht 638.12 million in 2018. This was mostly due to an increase in revenues from Inpatients

% of net profit margin comparing with Q2 2016. Apart from the additional costs of SBT’s impairment, the increment of gross and net profit was mostly caused by the improvement of products’ spread margin

machines, as well as the decrease in production cost while there is no significant increase in other expenses. Overall, it resulted in the improvement of net profit margin for the group as mentioned. Please

MTHB or 4.8% of net profit margin comparing with Q3 2016. Apart from the additional costs of SBT’s liquidation, the increment of gross and net profit was mostly caused by the improvement of products

55.98% and 56.10% respectively which is resulting from the proper management of manpower at stores and back office including the better results from the process improvement project and more staff training

issued in July 2017. Compared to the preceding quarter, 3Q17 revenues grew by 4% with an improvement in net earnings of 12%, mainly attributed to higher contribution from NVD, lower SG&A expenses and

. Meanwhile, net plant and equipment increased by Baht 49.62 million from building under construction at Chonburi branch to support business expansion and investment for production line improvement of spray

increased 14.30 million baht or 1.18% comparing to the same period last year, mainly from the rise of labour wages and the cost of automation system improvement. 3. Selling and Administrative Expense

addition, The Company also incurs the improvement cost in automotive business oversea. 4. Financial cost was decreased by 26.1 million Baht or 107.4%, impacted by the exchange gain/loss on loans in foreign

all business sales promotion and sale marketing both domestic and international. 4. Share of profit from investment in associates decrease by 20.04 million Baht or 31.75 %, from Factory improvement